Research ArticlePreeclampsia

Regulator of G protein signaling 5 is a determinant of gestational hypertension and preeclampsia

See allHide authors and affiliations

Science Translational Medicine  03 Jun 2015:
Vol. 7, Issue 290, pp. 290ra88
DOI: 10.1126/scitranslmed.aaa5038

You are currently viewing the editor's summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

This article has a correction. Please see:

Drugs may play a PPARt against preeclampsia

Preeclampsia is a vascular disorder of pregnancy, with symptoms including hypertension and loss of protein in the urine. The underlying causes of preeclampsia are not yet understood, and the only effective treatment is preterm delivery of the infant, which poses many risks for the child. Holobotovskyy et al. determined that a vascular protein called RGS5 plays an important role in the regulation of blood pressure during pregnancy and that a lack of this protein causes a preeclampsia-like syndrome in mouse models. These mice could be effectively treated with drugs called PPAR agonists, some of which are already approved for diabetes in humans, suggesting a potential therapeutic approach for preeclampsia.

View Full Text

Stay Connected to Science Translational Medicine